HSF1 and neurodegenerative disease: Most neurodegenerative diseases are “protein misfolding disorders” that could therapeutically benefit from active small molecules that regulate HSF1 or modulate chaperone activities that could possibly ameliorate the prevailing imbalance in protein homeostasis.